APEX-NET:基于平扫CT的急性胰腺炎自动评估网络
本研究基于五个中心3383例患者(急性胰腺炎与非急性胰腺炎),开发并验证深度学习框架APEX-NET,利用平扫CT实现胰腺分割、急性胰腺炎诊断及严重程度分级。APEX-NET通过特征映射模块从配对平扫与增强CT中学习模拟增强特征,在多个内外部队列中取得较高诊断及分级效能,并与高年资放射科医生表现相当。
要点
- APEX-NET仅依赖平扫CT即可诊断急性胰腺炎并预测严重程度,减少对增强CT时机依赖。
- 严重程度预测显著优于单纯平扫CT模型,在年龄、性别、病因亚组中保持优势。
- 模型诊断效能与高年资放射科医生相当,优于低年资医生,具有临床流程整合潜力。
核心结论
- APEX-NET基于平扫CT可实现急性胰腺炎准确诊断与早期严重程度分层,具备克服增强CT评估固有延迟的临床整合潜力。
研究设计与样本
- 研究类型为五中心回顾性及前瞻性研究,共纳入3383例患者,包括急性胰腺炎及非急性胰腺炎(腹痛患者和健康个体)。
- 使用3个内部队列和2个外部队列训练并评估胰腺分割、急性胰腺炎诊断及严重程度预测。
- 参考标准为修订版亚特兰大分类,将严重程度分为轻度、中度重症和重症。
- 通过配对平扫CT与增强CT特征学习构建特征映射模块,从平扫CT推导模拟增强CT特征。
- 评价指标包括Dice相似系数、受试者工作特征曲线下面积(AUC)和准确率。
诊断标准与关键数值
- 急性胰腺炎诊断方面,APEX-NET在验证队列、内部测试队列及两个外部测试队列的AUC分别为0.949、0.958、0.981和0.955。
- 严重程度预测方面,APEX-NET显著优于平扫CT模型(p<0.05),验证队列宏平均AUC为0.873,内部测试队列宏平均AUC为0.872。
- 在几乎全部年龄、性别和病因亚组中均显示APEX-NET的优势。
- 阅片者研究中,APEX-NET表现与高年资放射科医生相当,优于低年资放射科医生(p<0.05)。
临床应用与阅片要点
- 平扫CT作为急性胰腺炎初始检查手段,APEX-NET可在无增强条件下提供早期严重程度预测,帮助把握关键干预时间窗。
- 对不能耐受对比剂或需避免增强延迟的患者,该模型可作为替代性评估工具,辅助临床分流与治疗决策。
局限性
- 原文未具体报告模型在外部数据、扫描设备及成像参数差异下的失效模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate APEX-NET for early diagnosis and severity stratification of acute pancreatitis (AP) using non-contrast CT (NCCT), by leveraging contrast-enhanced CT (CECT) feature learning.
MATERIALS AND METHODS: This five-center retrospective and prospective study included 3383 patients, comprising AP and Non-AP (abdominal pain patients and healthy individuals) patients. APEX-NET was trained and evaluated to perform pancreas segmentation, AP diagnosis (AP vs Non-AP), and severity prediction (mild, moderately severe, or severe per the revised Atlanta classification) using 3 internal and 2 external cohorts. A feature mapping module was employed to derive simulated CECT features from NCCT based on paired NCCT-CECT feature learning. The model was further evaluated with subgroup analyses, and a reader study was conducted by comparing its performance with six radiologists of varying experiences. Evaluation metrics included the Dice similarity coefficient, area under the receiver operating characteristic curve (AUC), and accuracy.
RESULTS: For AP diagnosis, APEX-NET achieved AUCs of 0.949, 0.958, 0.981, and 0.955 in the validation, internal, and two external testing cohorts, respectively. For severity prediction, APEX-NET significantly outperformed the NCCT model (p < 0.05), with macro-average AUCs of 0.873 (validation) and 0.872 (internal testing). The advantage of APEX-NET had been demonstrated in almost all the age, gender, and etiology subgroups. In the reader study, APEX-NET performed comparably to senior radiologists and superior to junior radiologists (p < 0.05).
CONCLUSION: APEX-NET enables accurate NCCT-based diagnosis and early severity stratification of AP, demonstrating strong potential for clinical integration to overcome the inherent delay of CECT-based assessment.
KEY POINTS: Question The absence of an accurate method for predicting AP severity from early NCCT, the initial diagnostic scan, thus forgoing the critical intervention window. Findings Achieve accurate severity prediction for AP by incorporating contrast-enhanced feature learning. Demonstrate robust performance across diverse demographic groups, etiologies, and imaging parameters. Clinical relevance The APEX-NET, an integrated deep learning framework using NCCT, accelerated the diagnosis and severity stratification of AP, demonstrating performance comparable to senior radiologists and direct potential for clinical workflow integration by reducing reliance on delayed contrast-enhanced scans.
引用
- Wang, Huang, Xue, et al. APEX-NET: automated pancreatic evaluation network using early non-contrast CT. Eur Radiol. 2026. PMID: 42377437. doi:10.1007/s00330-026-12683-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。